GlassScriptPhysician profile
Debbie Gloria
NPI 1902819931
$3,728.85
in general payments reported to CMS, 2019-2025
27 companies · $802 in 2025
The $802 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $429 · 2022: $1,101 · 2023: $800 · 2024: $597 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,100 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,099.95 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $668.55 | 2022-2025 | |
| Janssen Biotech, INC. | $555.93 | 2022-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $355.96 | 2021-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $255.00 | 2022-2025 | Adbry, Anzupgo |
| Incyte Corporation | $223.88 | 2022-2024 | Opzelura |
| Vyne Pharmaceuticals INC. | $219.04 | 2021 | |
| Pfizer INC. | $175.96 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $151.81 | 2022-2025 | |
| Genzyme Corporation | $113.14 | 2023-2025 | |
| Boston Scientific Corporation | $108.78 | 2021 | |
| Janssen Scientific Affairs, LLC | $108.38 | 2022 | |
| Galderma Laboratories, L.P. | $101.40 | 2022-2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $96.26 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $74.04 | 2023-2024 | Sotyktu |
| Amgen INC. | $70.78 | 2021-2023 | Otezla |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $58.47 | 2023-2025 | Klisyri |
| Arcutis Biotherapeutics, INC. | $54.36 | 2023-2024 | Zoryve |
| Abbott Laboratories | $48.99 | 2023-2025 | Amplatzer Talisman, Thoratec Heartmate 3 Lvas Implant Kit |
| Lilly USA, LLC | $48.60 | 2021-2023 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $45.93 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.70 | 2025 | Cabtreo |
| Organon LLC | $34.72 | 2025 | |
| Journey Medical Corporation | $30.44 | 2023 | |
| Ucb, INC. | $28.75 | 2023 | Cimzia |
| Verrica Pharmaceuticals INC. | $23.12 | 2023 | Ycanth |
| Dermavant Sciences, INC. | $19.90 | 2023 | Vtama |
| Biofrontera INC. | $16.96 | 2025 | Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Gloria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.